Trials / Completed
CompletedNCT01290068
Visual Outcomes After Cataract Surgery: Multifocal AcrySof® IQ ReSTOR® Intraocular Lenses Versus Monofocal Intraocular Lenses
Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof® ReSTOR IOL Implantation Compared to Monofocal IOL Implantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess and compare visual outcomes of the AcrySof® IQ ReSTOR® +3.0 D intraocular lens (IOL) to a commercially available monofocal IOL in cataract patients.
Detailed description
This study included subjects with bilateral age-related cataracts and either no preoperative corneal astigmatism, or preoperative regular corneal astigmatism confirmed by autokeratometry of ≤2.5 D.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL | Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient |
| DEVICE | AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL | Multifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient |
| DEVICE | Monofocal IOL | Monofocal IOL implanted for long-term use over the lifetime of the cataract patient |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-02-04
- Last updated
- 2018-07-02
- Results posted
- 2017-03-06
Source: ClinicalTrials.gov record NCT01290068. Inclusion in this directory is not an endorsement.